New User:

Forgot your password?

Stock Market & Financial Investment News

Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
September 26, 2014
10:18 EDTJBL, BBBYOptions with decreasing implied volatility
Subscribe for More Information
08:12 EDTJBLJabil Circuit looks to be turning the corner, says Argus
Subscribe for More Information
September 25, 2014
17:09 EDTORCLAlphaOne's Dan Niles sees 'cloud' as negative to Oracle's legacy business
Dan Niles is speaking on CNBC.
10:45 EDTJBLJabil Circuit falls amid market pullback despite Q4 earnings beat
Subscribe for More Information
10:33 EDTBBBYOptions with decreasing implied volatility
Options with decreasing implied volatility: VHC RPRX SFLY VNET YHOO RHT KMX BBBY CCL ACN
10:13 EDTJBLHigh option volume stocks
Subscribe for More Information
09:13 EDTJBLOn The Fly: Pre-market Movers
HIGHER: LipoScience (LPDX), up 63% after agreeing to be acquired by LabCorp (LH) for $5.25 per share in cash... Magnum Hunter (MHR), up 12.5% after announcing that throughput volumes on Eureka Hunter's gas gathering pipeline system have increased to about 316,500 MMBtu per day... Jabil Circuit (JBL), up 4.7% following its report of better than expected fourth EPS and revenue... (JD), up 0.7% after the stock was initiated with an Outperform rating at Macquarie. LOWER: Yahoo (YHOO), down 0.6% after RBC Capital downgraded its rating on the stock to Sector Perform from Outperform, saying the risk/reward is less attractive following Alibaba's (BABA) initial public offering... HB Fuller (FUL), down 15% after reporting quarterly results and guidance that missed analyst estimates... Omnova Solutions (OMN), down 10.8% after its Q3 adjusted EPS missed expectations... Pacira Pharmaceuticals (PCRX), down 9.2% after receiving an FDA warning letter over certain promotional materials on Exparel.
08:08 EDTORCLOracle extends partnership with Box
Oracle announced that the company has extended its partnership with Box. Oracle has integrated Oracle Marketing Cloud with Box. The integration is designed to enable marketers to quickly and effectively plan, produce and publish marketing content that builds digital dialogue with customers, improving lead quality and turning advocates into ambassadors, ultimately creating ideal customers for their businesses. The integration gives Oracle Marketing Cloud customers the ability to develop content with commonly used tools such as Microsoft Office products and PDFs and instantly convert these into HTML5, simplifying the creation of effective marketing campaigns. Availability of the new integration features is planned for Spring 2015.
06:02 EDTRADStocks with implied volatility movement; RAD WLT
Stocks with implied volatility movement; Rite Aid (RAD) 59, Walter Energy (WLT) 131 according to iVolatility.
September 24, 2014
18:19 EDTJBLOn The Fly: After Hours Movers
UP AFTER EARNINGS: Jabil Circuit (JBL), up 3.8% after reporting fourth quarter results and fiscal 2015 guidance. ALSO HIGHER: Rexahn Pharmaceuticals (RNN), up 11.8% after announcing that the FDA has granted Orphan Drug Designation for its drug RX-3117 for the treatment of patients with pancreatic cancer... xG Technology (XGTI), up 7.8% after announcing stock purchase agreements for up to $16M... Marchex (MCHX), up 2.1% after receiving notice of termination from Allstate (ALL). DOWN AFTER EARNINGS: HB Fuller (FUL), down 11.3% after reporting second quarter results and guidance below analyst estimates.
17:35 EDTJBLJabil Circuit targets FY15 growth of 0%-5% for EMS segment, margins of 2%-4%
Targets FY15 growth of 8%-10% for diversified manufacturing services segment, margins of 5%-7%. Expects to make "substantial investments" in FY15. Says exploring new, "non-traditional markets." Sees strong operating cash flows going forward. Sees FY15 operating margins in mid 3% range. Sees FY15 CapEx $350M-$450M, weighted towards DMS segment. Comments from company's Q4 earnings conference call.
16:22 EDTBBBYOn The Fly: Closing Wrap
Stocks on Wall Street were higher after a report showed that sales of new homes rose to their highest level in over six years in August. The volume and news flow were relatively light, which may be the case again tomorrow as many market participants celebrate the Jewish holiday of Rosh Hashanah. ECONOMIC EVENTS: In the U.S., new home sales rose 18.0% in August to a 504K unit rate, which was much higher than the expected 4.4% increase. COMPANY NEWS: Bed Bath & Beyond (BBBY) advanced $4.64, or 7.4%, to $67.33 after the home goods retailer last night reported second quarter earnings and revenue that surpassed analysts' consensus estimates. The better than expected report and rise in the stock comes a day after William Blair downgraded the stock yesterday morning... Citizen Financial (CFG), the U.S. retail bank unit of Royal Bank of Scotland (RBS), became the year's second largest IPO behind Alibaba (BABA) after 140M shares began trading on the NYSE this morning. The stock ended it first day up $1.58, or 7.35%, at $23.08, which was far cry from the advance seen by another of the day's new stock debuts. CyberArk (CYBR) priced 5.36M shares at $16.00, opened for trade at $25.00 and ended the day at $29.94, making for a rise of over 87% from its IPO pricing. MAJOR MOVERS: Among the notable gainers was Acorda Therapeutics (ACOR), which advanced $8.27, or 28.18%, to $37.62 after the company agreed to acquire Civitas Therapeutics for $525M in cash. Civitas, which was private, had been scheduled to come public via an IPO that was expected to happen later this week prior to the deal announcement. Also higher was Hasbro (HAS), which rose $2.01, or 3.8%, to $54.95 after striking a deal that gives the company global rights, excluding Japan, to develop dolls based on Disney's (DIS) princess characters, as well as Frozen, beginning in 2016. Mattel (MAT), which currently holds those rights, slid 40c, or 1.25%, to $31.67 in the wake of the news. Also lower were shares of Skechers (SKX), which fell $5.69, or 9.8%, to $52.40 after research firm SportscanInfo reported that the footwear maker's sales had fallen 3% last week. However, Sterne Agee recommended buying the stock on the weakness. INDEXES: The Dow rose 154.19, or 0.9%, to 17,210.06, the Nasdaq gained 46.53, or 1.03%, to 4,555.22, and the S&P 500 added 15.53, or 0.78%, to 1,998.30.
16:15 EDTJBLJabil Circuit sees FY15 revenue $16.5B-$18.0B, consensus $16.35B
Subscribe for More Information
16:07 EDTJBLJabil Circuit up over 6% following Q4 results, FY15 guidance
16:05 EDTJBLJabil Circuit sees Q1 Diversified Manufacturing Services revenue up 6%
Subscribe for More Information
16:04 EDTJBLJabil Circuit sees Q1 core EPS 41c-53c, consensus 41c
Sees Q1 revenue $4.2B-$4.4B, consensus $4.11B.
16:03 EDTJBLJabil Circuit backs FY15 core EPS $1.65-$1.95, consensus $1.74
Subscribe for More Information
16:02 EDTJBLJabil Circuit reports Q4 core EPS 5c, consensus 0c
Reports Q4 revenue $4.1B, consensus $3.83B.
15:43 EDTJBLJabil Circuits October 21 straddle priced for 8.2% move into Q4
15:34 EDTJBLJabil Circuit technical comments ahead of results
In the prior three months the shares have underperformed the averages, trading flat. The trading range has been between $20 at the low and $21.50 at the high. In the longer-term view, the shares have been in a bullish trend since hitting lows back in May. The stock does tend to advance and consolidate which is characteristic of the current price behavior. On a breakout above $21.50 on better than expected news, next resistance would be at $22.68. On progressively stronger news, the following resistance levels could become upside objectives: $23.90, and then the 52-week high at $24.13. If the news does not support additional upside, the following support levels could become downside objectives: $19.63, $18.37, $17.19, and $16.12. The short-base in the shares is moderate suggesting traders are not positioned for negative news. That could exacerbate the downside reactions on a negative surprise.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use